CalciMedica, Inc.
CALC
$0.72
-$0.11-13.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -27.67% | -31.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.95% | -15.15% | |||
| Operating Income | 21.95% | 15.15% | |||
| Income Before Tax | -37.88% | -31.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.88% | -31.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.88% | -31.03% | |||
| EBIT | 21.95% | 15.15% | |||
| EBITDA | 21.87% | 15.15% | |||
| EPS Basic | -31.22% | -30.31% | |||
| Normalized Basic EPS | -31.22% | -30.34% | |||
| EPS Diluted | -31.22% | -30.31% | |||
| Normalized Diluted EPS | -31.22% | -30.34% | |||
| Average Basic Shares Outstanding | 5.07% | 0.54% | |||
| Average Diluted Shares Outstanding | 5.07% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||